MJFF in the News

MJFF CEO and other Parkinson’s disease (PD) experts — people living with the disease and scientists from around the world — participated in a three-episode radio series on "The Truth about Parkinson's" on the BBC.

Ken Griffin, Founder and CEO of the Chicago-based global investment firm Citadel and MJFF Co-Founder Debi Brooks spoke with Fortune’s Sy Mukherjee on the $10-million program spurring a scientific race in pursuit of a game-changing tool in Parkinson’s research.  

Fortune Magazine released their sixth annual list of the "World's Greatest Leaders" with Michael J. Fox listed at 22 for his leadership with the Foundation and our work to end Parkinson's disease.

Michael J. Fox and Debi Brooks chat with Fortune about how patients are driving research forward.

Michael J. Fox sat down for an intimate Q&A with the New York Times Magazine’s Talk column.

The column discusses the Foundation's "de-risking" strategy and impact, using the recent FDA approval of Inbrija as a proof point on the current transformation in Parkinson's research.

Timed during the 12th annual Parkinson's Disease Therapeutics Conference, "Forbes" covered a historical moment for the promising genetic target LRRK2 and the Foundation's role in moving research forward.

Variety names Michael J. Fox philanthropist of the year. In the featured article, Michael expresses optimism navigating his Parkinson disease and the Foundation’s breakthrough initiatives, Fox Insight and PPMI.